0.1.0 - ci-build
AGESMedicinalProductR5 - Local Development build (v0.1.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
Draft as of 2025-07-01 |
Mappings for the at-medprod-administrableproductdefinition resource profile.
No Mappings Found
No Mappings Found
Name | FiveWs Pattern Mapping | IDMP Mapping | RIM Mapping![]() |
---|---|---|---|
![]() ![]() |
administrative.medication |
Pharmaceutical Product |
|
![]() ![]() ![]() |
|||
![]() ![]() ![]() |
|||
![]() ![]() ![]() |
|||
![]() ![]() ![]() |
|||
![]() ![]() ![]() |
Act.text? | ||
![]() ![]() ![]() |
N/A | ||
![]() ![]() ![]() |
N/A | ||
![]() ![]() ![]() |
N/A | ||
![]() ![]() ![]() |
FiveWs.class |
PhPID |
|
![]() ![]() ![]() ![]() |
n/a | ||
![]() ![]() ![]() ![]() |
n/a | ||
![]() ![]() ![]() ![]() |
Role.code or implied by context | ||
![]() ![]() ![]() ![]() |
Role.code or implied by context | ||
![]() ![]() ![]() ![]() |
II.root or Role.id.root | ||
![]() ![]() ![]() ![]() |
II.extension or II.root if system indicates OID or GUID (Or Role.id.extension or root) | ||
![]() ![]() ![]() ![]() |
Role.effectiveTime or implied by context | ||
![]() ![]() ![]() ![]() |
II.assigningAuthorityName but note that this is an improper use by the definition of the field. Also Role.scoper | ||
![]() ![]() ![]() |
n/a |
||
![]() ![]() ![]() |
(link to Medicinal Product) |
||
![]() ![]() ![]() |
Pharmaceutical Product.Administrable Dose Form |
||
![]() ![]() ![]() |
Pharmaceutical Product.Unit of Presentation |
||
![]() ![]() ![]() |
n/a (this is the link from Pharmaceutical Product to the Manufactured Item(s)) |
||
![]() ![]() ![]() |
Pharmaceutical Product.Ingredient (see also FHIR Ingredient resource) |
||
![]() ![]() ![]() |
Pharmaceutical Product.Device |
||
![]() ![]() ![]() |
n/a |
||
![]() ![]() ![]() |
Pharmaceutical Product Characteristics |
||
![]() ![]() ![]() ![]() |
n/a | ||
![]() ![]() ![]() ![]() |
n/a | ||
![]() ![]() ![]() ![]() |
N/A | ||
![]() ![]() ![]() ![]() |
|
||
![]() ![]() ![]() ![]() |
|
||
![]() ![]() ![]() ![]() |
Pharmaceutical Product Characteristics.Status |
||
![]() ![]() ![]() |
Pharmaceutical Product.Route of Administration |
||
![]() ![]() ![]() ![]() |
n/a | ||
![]() ![]() ![]() ![]() |
n/a | ||
![]() ![]() ![]() ![]() |
N/A | ||
![]() ![]() ![]() ![]() |
Route of Administration.Route of Administration |
||
![]() ![]() ![]() ![]() |
Dosing and Route of Administration.First dose in humans (Investigational Medicinal Product) |
||
![]() ![]() ![]() ![]() |
Dosing and Route of Administration.Maximum single dose (Investigational Medicinal Product) |
||
![]() ![]() ![]() ![]() |
Dosing and Route of Administration.Maximum dose per day (Investigational Medicinal Product) |
||
![]() ![]() ![]() ![]() |
Dosing and Route of Administration.Maximum dose per treatment period (Investigational Medicinal Product) |
||
![]() ![]() ![]() ![]() |
Dosing and Route of Administration.Maximum treatment period (Investigational Medicinal Product) |
||
![]() ![]() ![]() ![]() |
n/a |
||
![]() ![]() ![]() ![]() ![]() |
n/a | ||
![]() ![]() ![]() ![]() ![]() |
n/a | ||
![]() ![]() ![]() ![]() ![]() |
N/A | ||
![]() ![]() ![]() ![]() ![]() |
n/a |
||
![]() ![]() ![]() ![]() ![]() |
n/a |
||
![]() ![]() ![]() ![]() ![]() ![]() |
n/a | ||
![]() ![]() ![]() ![]() ![]() ![]() |
n/a | ||
![]() ![]() ![]() ![]() ![]() ![]() |
N/A | ||
![]() ![]() ![]() ![]() ![]() ![]() |
n/a |
||
![]() ![]() ![]() ![]() ![]() ![]() |
n/a |
||
![]() ![]() ![]() ![]() ![]() ![]() |
n/a |
||
![]() |